The trial results are critical, as it brings Eli Lilly's pill one step closer to becoming a new, needle-free alternative for ...

Eli Lilly is exploring partnerships with Indian pharma firms to market its anti-diabetes and weight loss drug Mounjaro, ...

Eli Lilly (NYSE: LLY) has been around for almost 150 years, finding ways to innovate and grow. The next largest healthcare ...

Dr. Jitendra Singh, a renowned endocrinologist himself, emphasized the unique metabolic challenges faced by India due to its ...

Customers who struggle to afford the $1,000-plus list price for weight-loss drugs Zepbound and Wegovy can buy now and pay ...

Foreign CEOs, including Tim Cook of Apple, as well as Republican Sen. Steve Daines are in Beijing for the two-day China ...

President Donald Trump’s tariffs on pharmaceuticals "to come at some point" as companies promise to build infrastructure in ...

Lilly beats Novo Nordisk to launch weight-loss ... DNA testing firm 23andMe files for bankruptcy to sell itself; CEO leaves after failed bids 6:03 AM UTC Healthcare & Pharmaceuticalscategory ...

Global demand for Lilly's diabetes and weight-loss drugs has soared, with the launch presenting a big market opportunity for ...

Johnson & Johnson follows Eli Lilly in spending billions on U.S. manufacturing after President Donald Trump threatened major ...

Eli Lilly stock has generated fantastic returns ... it has announced over $50 billion in manufacturing investments, which CEO David Ricks says is "the largest pharmaceutical expansion investment ...